Govorestat is a central nervous system (CNS) penetrant Aldose Reductase Inhibitor (ARI) being developed for the treatment of multiple rare diseases including Classic Galactosemia, Sorbitol ...

Rallybio Corporation , a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastating rare diseases, today announced the publication ...

India’s Ministry of Health has taken no steps to stop other pharmaceutical companies from continuing to manufacture and sell ...

Patrick Smith, President of Drug Development Solutions, Certara. Inflation and the Covid-19 pandemic have put pharmaceutical ...

Adverse drug reactions (ADRs) and medication adherence are critical aspects of healthcare, particularly within pediatric and obstetric fields. Pediatric patients and pregnant women are often more ...

A preliminary hearing has been scheduled for a Tahlequah woman accused of drug trafficking and cultivation. On June 20, Lia Vang, 49, and another individual, were found to be in possession of ...

Substance use disorders are notoriously difficult to treat, as it is challenging to intervene in a drugs' effect on the brain ...

Researchers have developed a breakthrough system to deliver large therapeutic molecules into the brain, overcoming the challenges of the blood-brain barrier.

A Louisiana law that reclassified abortion-inducing drugs as controlled substances has made it more difficult for doctors to ...

The NHS programme may be new, but the process of “repurposing” (which is similar to using a drug “off label”) has actually long been used in pharmacology, including some familiar household medications ...

SVIMS Director Dr RV Kumar, Medical Superintendent Dr Ram, Dr K Umamaheswara Rao and others taking part in AMR awareness programme in Tirupati on Saturday ...